Sotera Health Co (SHC)
Return on total capital
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | ||
---|---|---|---|---|
Earnings before interest and tax (EBIT) | US$ in thousands | 276,692 | 248,350 | 256,733 |
Long-term debt | US$ in thousands | 2,223,670 | 1,747,120 | 1,743,530 |
Total stockholders’ equity | US$ in thousands | 443,734 | 350,238 | 586,096 |
Return on total capital | 10.37% | 11.84% | 11.02% |
December 31, 2023 calculation
Return on total capital = EBIT ÷ (Long-term debt + Total stockholders’ equity)
= $276,692K ÷ ($2,223,670K + $443,734K)
= 10.37%
Sotera Health Co's return on total capital has shown a consistent trend over the past five years. The company's return on total capital has ranged from 8.59% in 2019 to 10.83% in 2021, with a slight decrease to 10.08% in 2023. This indicates that the company has been effectively utilizing its total capital to generate profits for its stakeholders. Overall, Sotera Health Co's return on total capital demonstrates a stable performance and a sound financial position over the years.
Peer comparison
Dec 31, 2023
Company name
Symbol
Return on total capital
Sotera Health Co
SHC
10.37%
DaVita HealthCare Partners Inc
DVA
151.76%
Progyny Inc
PGNY
11.24%